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Hala Boulos6, Patrick A Curmi3 and Hatem El-Shanti1,7*Abstract
Background: A consanguineous Arab family is affected by an apparently novel autosomal recessive disorder
characterized by cognitive impairment, failure-to-thrive, hypotonia and dysmorphic features including bilateral ptosis
and epicanthic folds, synophrys, midface hypoplasia, downturned mouth corners, thin upper vermillion border and
prominent ears, bilateral 5th finger camptodactyly, bilateral short 4th metatarsal bones, and limited knee mobility
bilaterally.
Methods: The family was studied by homozygosity mapping, candidate gene mutation screening and whole
Exome Next Generation Sequencing of a single affected member to identify the offending gene and mutation.
The mutated gene product was studied by structural bioinformatics methods.
Results: A damaging c.C5054G mutation affecting an evolutionary highly conserved amino acid p.S1685W was
identified in the ZNF407 gene at 18q23. The Serine to Tryptophane mutation affects two of the three ZNF407
isoforms and is located in the last third of the protein, in a linker peptide adjoining two zinc-finger domains.
Structural analyses of this mutation shows disruption of an H-bond that locks the relative spatial position of the
two fingers, leading to a higher flexibility of the linker and thus to a decreased probability of binding to the target
DNA sequence essentially eliminating the functionality of downstream domains and interfering with the expression
of various genes under ZNF407 control during fetal brain development.
Conclusions: ZNF407 is a transcription factor with an essential role in brain development. When specific and
limited in number homozygosity intervals exist that harbor the offending gene in consanguineous families, Whole
Exome Sequencing of a single affected individual is an efficient approach to gene mapping and mutation
identification.
Keywords: Zinc finger proteins, Cognitive impairment, Homozygosity mapping, Next generation exome
sequencing, In-silico protein modelingBackground
A pregnant woman and her first cousin spouse, both of
Qatari ethnic origin, presented for prenatal diagnosis be-
cause of family history of two previous male children
with marked cognitive impairment and dysmorphic fea-
tures, as well as, two early first trimester abortions. The* Correspondence: elshantih@smgc.org.qa
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article, unless otherwise stated.cause of the miscarriages is unknown. To identify the
gene and mutation responsible for the phenotype and to
propose a possible underlying molecular mechanism,
Homozygosity mapping, candidate gene screening, Next
Generation Exome Sequencing and bioinformatics ana-
lyses of the resulting data were utilized.Methods
Homozygosity mapping was performed for all family mem-
bers utilizing the Human Mapping 370 K-Cyto12 SNP
genotyping array [Illumina, USA]. For the determination oftral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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HomozygosityMapper software [1].
Sanger sequencing using Big-dye terminator v.3.1 cycle
sequencing [Applied Biosystems, USA] was performed
on an ABI 3730 automatic sequencer [Applied Biosys-
tems, USA] to screen for mutations in candidate genes,
perform population frequency studies for variants and
determine co-segregation of variants with the disease
phenotype within the family.
Whole Exome target enrichment Next Generation Se-
quencing was performed on ABI SOLiD4 platform [Applied
Biosystems] according to manufacturer’s specifications. DNA
library preparation was with TargetSeq™ Exome Enrichment
system [Applied Biosystems] as multiplex fragments libraries
utilizing both the SOLiD® Fragment Library Construction
Kits and SOLiD® Fragment Library Barcoding Kit Module
1–16 for the SOLiD® 4 System. Bead preparation and enrich-
ing was done on an EZ Bead Emulsifier, Amplifier and
Enricher utilizing E80 scale. Sequencing modality was
with multiplex fragment paired-end.
Bioinformatic analyses of whole Exome NGS data was
as follows: Raw data files (in a proprietary XSQ file for-
mat) were analyzed with the LifeTechnologies LifeScope
v2.5.4 software running on a dedicated cluster to align
the reads produced by the SoLID to a hg19 whole gen-
ome reference sequence, sourced from the University of
California, Santa Cruz Genome Informatics Group (UCSC).
The aligned BAM files were validated, duplicate sequences
were identified and removed and incorrectly identified
Mate-Pairs were corrected using the Picard v1.87 software.
The Genome Analysis Tool Kit (GATK) v3.0.0 was applied
to the ‘corrected’ output files to recalibrate the base quality
scores, using machine learning to model any systematic er-
rors in the data; carry out localized realignments around
possible insertion/deletion sequences to ensure mapping
accuracy; identify viable variants from the sequence reads;
and recalibrate the variants to ensure accuracy of the vari-
ant calling, in a variant-type specific manner. Once a suit-
able list of variants was produced in this manner, the list
was filtered using in-house scripts to confirm variant zygos-
ity and identify those variants that conform to the inhe-
ritance model. These variants were annotated using an
in-house script in conjunction with Annovar to produce an
annotated list of variants with the most recent information
available on a number of reference websites.
As the three-dimensional [3-D] structure of the ZNF407
protein is not available in the Protein Data Bank (PDB),
sequence homology methods were utilized to construct 3-
D models of the wild type and mutant zinc finger domains
18 and 19 of ZNF407. BLAST-searches (blast.ncbi.nlm.nih.
gov/Blast.cgi) were performed within the PDB for crystal
structures of homologous proteins. Once these were identi-
fied, the CLUSTALW software (www.ebi.ac.uk) was utilized
to insure correct sequence alignments between domains 18and 19 of ZNF407 and the retrieved zing finger structures
found in the PDB. Focus was on complexes with double-
stranded DNA only so as to have the proper bioactive con-
formation of the tandem finger. A high sequence homology
with the Aart protein in complex with dsDNA (PDB code
2I13) was identified. The 3-D model of ZNF407 was then
generated with the Modeller software (version 9v8) [2]
based on the crystal structure of Aart in complex with
DNA as a template (PDB code 2I13). A cycle of energy
minimizations was then performed to obtain a stable con-
formation of the 3-D model. The quality of the model gen-
erated was finally assessed with DOPE score [3] and the
Ramachandran plot of the best model was calculated by
ProCheck [4] to discriminate unfavorable amino-acids
backbone conformations. Three-Dimensional ribbon repre-
sentations of the models were obtained with the molecular
graphics program PyMOL (www.pymol.org). To generate
the 3-D model of the mutant, Serine 1685 was replaced for
a Tryptophan residue in the second finger of the 18–19 tan-
dem finger domain and submitted to the same protocol as
that used for the wild type complex. Thereafter both
models were compared for an insight into the structural
and thermodynamic stability effects of the mutation. To
generate the 3-D model of the mutant, Serine 1685 was re-
placed for a Tryptophan residue in the second finger of the
18–19 tandem finger domain and submitted to the same
protocol as that of the wild type complex. Thereafter, both
models were compared for an insight into the structural
and thermodynamic stability effects of the mutation.
The study was conducted in accordance with the pro-
visions of the Declaration of Helsinki and an informed
consent was obtained by the guardian of the affected
participating family member.
Results
Clinical presentation
Individual II:2 is an 11-year-old boy who was born at full
term after an uneventful pregnancy, labor and delivery.
Although the birth growth parameters are not recorded,
the parents recall that all measurements were within
normal limits, including the head circumference. Cur-
rently, his height is 124 cm (below the 3rd%ile) and his
weight is 27 kg (at the 3rd%ile) and is reported to have a
normal head circumference. His development has been
delayed; he sat without support at 3 years and walked in-
dependently, with an awkward gait and bent knees, be-
tween the age of 4 and 5 years. He started to talk with
very limited speech at the age of 8 years and is not toilet
trained till now. Evaluation by Leiter-R [Leiter Inter-
national Performance Scale] indicated severe cognitive
and developmental disability with a Brief IQ of 36. The
physical examination showed bilateral ptosis and epican-
thic folds, synophrys, strabismus, midface hypoplasia,
downturned corners of the mouth, thin upper vermillion
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sent lobules. He had bilateral short fourth metatarsal
bones with overriding toes, bilateral proximal insertion
of the thumbs and persistent fetal pads on fingers and
toes. He is hypotonic with exaggerated deep tendon re-
flexes. The skeletal survey showed normal hips and mild
kyphosis without scoliosis. Conventional karyotyping,
Array CGH, Echocardiogram and abdominal ultrasound
were all reported as normal. An MRI of the brain is nor-
mal, without any evidence of structural abnormalities.
Hearing test (auditory evoked potential) has been re-
ported to be normal.
Individual II:4 is a 5-year-old boy who was born at
37 weeks after an uneventful pregnancy, labor and deliv-
ery. His birth weight is 2.95 kg and length is 48 cm and
head circumference of 33.5 cm, all are within normal
limits. Currently, his height is 95 cm (below the 3rd%ile)
and his weight is 15 kg (at the 3rd%ile) and is reported
to have a normal head circumference. His development
has been delayed; he currently sits without support and
attempts to pull himself to a stand. He babbles infre-
quently and reaches for objects and is not toilet trained
till now. Evaluation by Leiter-R [Leiter International Per-
formance Scale] could not be performed, and the Vin-
land Adaptive Behavior Scale gave a total scaled score of
164 and an adaptive behavior total grade of 38, which
denotes severe developmental and cognitive disability.
The physical examination showed bilateral ptosis and
epicanthic folds, synophrys, strabismus, midface hypo-
plasia, downturned corners of the mouth, thin upper
vermillion border and prominent ears with marked over-
folding and absent lobules (Figure 1). He has bilateral
camptodactyly of the fifth finger, bilateral proximal in-
sertion of the thumbs, overriding toes and persistent
fetal pads on fingers and toes. He is hypotonic with ex-
aggerated deep tendon reflexes. The skeletal survey
showed bilateral femoral joint subluxation, dysplastic leftFigure 1 Dysmorphic features of affected individual II-4: Bilateral pto
downturned corners of the mouth, thin upper vermillion border andacetabulum, and mild kyphosis without scoliosis. Con-
ventional karyotyping, Array CGH, Echocardiogram and
abdominal ultrasound were all reported as normal. An
MRI of the brain is normal, without any evidence of
structural abnormalities. The family history is remark-
able for first cousin parents, two early spontaneous abor-
tions and two normal siblings.
Homozygosity mapping was performed for all family
members (Figure 2) except II:5. The mutation-harboring
gene was mapped to four possible genome homozygosity
intervals: Hsa 8p [rs1786342/101,676,363 to rs4336584/
109,940,377, length 8.3 Mb], Hsa 14q [rs12431815/
40,004,891 to rs1958628/48,107,640, length 8.1 Mb], Hsa
15q [rs12148268/58,759,459 to rs4886727/75,957,375,
length 17.2 Mb], Hsa 18q [rs12454898/71,590,636 to
rs11081575/77,707,525, length 6.1 Mb]. A screen of genes
on these intervals, with respect to the clinical findings,
suggested a possible positional candidate gene MAP2K1
located on chromosome 15. The gene was screened by
DNA Sanger sequencing for pathogenic mutations but
none were identified. Furthermore, since both affected
individuals are males, the genotyping data were ana-
lyzed for shared regions on the X-chromosome between
the two affected males. One shared interval was identi-
fied [Hsa X, rs311183/2,724,756 to rs2681655/9,479,898,
length 6.8 Mb]. Four positional candidate X-linked genes
(taking into consideration the clinical findings): PRKX,
ARSF, ARSD and ARSH were screened for mutations by
DNA Sanger sequencing; again, no pathogenic muta-
tions were identified. Whole Exome target enrichment
Next Generation Sequencing of one of the affected indi-
viduals resulted in the identification of multiple exonic
non-synonymous homozygous variants, with only five
localizing in the four major homozygosity intervals. 1)
IGDCC4: c.G727A/p.D243N; 2) C15orf39: g.G46293956A/
p.R1029K; 3) TLN2: c.G6716A/p.R2239H; 4) PML: c.
G1487T/p.G496V; 5) ZNF407: c.C5054G/p.S1685W.sis and epicanthic folds, synophrys, midface hypoplasia,
prominent ears.
Figure 2 Pedigree of the family segregating for the ZNF407 c.C5054G/p.S1685W mutation. Genotypes are indicated. Consanguinity line
represents first cousin marriage. Two early miscarriages are not shown. Half shaded blocks indicate genotypes only. Full shaded blocks indicate
both genotypes and phenotypes for the affected individuals.
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time, was obtained through amniocentesis and was ge-
notyped genome-wide identical to all other family mem-
bers as well as for the c.C5054G/p.S1685W mutation.
The analyses indicated that II:5 is a carrier for the c.
C5054G/p.S1685W mutation (heterozygous) and the
genome-wide genotyping confirms heterozygosity for the
critical interval on chromosome 18 containing ZNF407.
At birth it was re-confirmed that individual II:5 was not
affected.
Discussion
Homozygosity mapping, screening of positional candi-
date genes, whole Exome Next Generation Sequencing
and data mining were utilized in the effort to identify
the disease causing gene and mutation for this appar-
ently novel rare autosomal recessive disease. Out of the
five potentially damaging variants identified within the
homozygosity intervals, the IGDCC4: c.G727A/p.D243N
[rs35223184]; and C15orf39: g.G46293956A/p.R1029K
[rs149175372] were immediately excluded since they
represent known common polymorphisms with >1%
population frequency [1000 Genomes and NCBI dbSNP
Build 135].
The third identified variant, TLN2 [c.G6716A/p.R2239H],
affects a non-conserved amino acid. The “alternate” amino-
acid Histidine is found as the “normal” amino-acid at that
position in numerous non-human species. A gene trap
mouse model with disrupted Taln2, as well as Taln2 knock-
out mice are viable and fertile but may display a milddystrophic phenotype in skeletal and cardiac muscles [5-7]
without any neurological findings as in the family under in-
vestigation. These render this variant as extremely unlikely
pathogenic in relation to the clinical phenotype of the
patients.
The fourth identified variant c.G1487T/p.G496V af-
fects a non-conserved amino acid in a known Promyelo-
cytic Leukemia tumor suppressor [PML] gene in Acute
Promyelocytic Leukemia (APL). PML mutations have
been detected in APL as well as in other hematopoietic
malignancies. Functional loss of PML does not relate at
all to the phenotype of the family [8], and again this vari-
ant is extremely unlikely to be pathogenic in relation to
the phenotype under investigation.
The fifth variant, a c.C5054G/p.S1685W at the zinc
finger transcription factor gene (ZNF407), was found to
affect an evolutionarily highly conserved amino acid. It
has damaging effects according to PolyPhen and SIFT
protein-modeling software [9,10], and it co-segregates
with the disease phenotype within the family. It is absent
in any of the publically available variant databases [1000
Genomes and NCBI dbSNP Build 135]. Furthermore, it
is absent in 400 ethnically matched control chromo-
somes, making it the only and most likely disease-
causing gene and mutation.
Zinc finger genes are found ubiquitously, and catego-
rized into several types based on the structure of their
binding residues, and their biological roles within the cell
[11,12]. Through their ability to bind to DNA, RNA &
proteins, zinc finger proteins facilitate numerous cellular
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control of hematopoiesis, regulation of gene expression,
cell differentiation, and development [13]. Their DNA-
binding domain is comprised of tandem repeats of two,
three or more fingers that can have different binding spec-
ificities. These tandem arrays, separated by amino acid
linkers, bind through sequence-specific contact to 2–4
bases in the major groove of the DNA, spaced at 3-bp in-
tervals [14,15]. Optimal binding is achieved through the
sequential binding and wrapping of the zinc finger do-
mains around the DNA [15].
The genomic sequence of ZNF407, as reported in the
Uniprot database of proteins [Uniprot consortium, 2012]
is 434,710 bp long and generates a 2,248 amino acid
protein product of 247,367 Da. with 22 zinc finger do-
mains. Each of the 22 zinc finger motifs comprises from
23 to 26 amino acid residues. The 22 zinc fingers come
in tandems of one (fingers 6, 7, 12 and 13), two (fingers
4–5, 8–9, 10–11), three (1–3, 14–16) and six (17–22)
fingers.
ZNF407 constitutes one of the 481 ultra-conserved el-
ements in the human genome, rendering it a function-
ally essential gene [16]. It presents three isoforms
produced by alternative splicing. Isoform 1 (Q9C0G0-1)
is the “canonical” sequence. Isoform 2 (Q9C0G0-2) differs
from the canonical sequence in amino acids 1811–1815
and amino acids 1816–2248 are missing. In isoform 3
(Q9C0G0-3), amino acids 1625–1660 are modified and
residues 1661–2248 are missing. This isoform thus does
not possess zinc fingers 18 to 22.
The c.C5054G [p.S1685W] mutation affects two of the
three ZNF407 isoforms. It is located in the last third of
the ZNF407 sequence and affects a Serine residue in the
linker between zinc finger domains 18 and 19. These
two zinc fingers belong to the 6-finger tandem comprising
fingers 17–22. Zink fingers 18 and 19 represent amino
acid residues F1656-H1680 and F1686-H1708, respect-
ively, and are missing in isoform 3. Perturbation or modi-
fication of the linker adjoining two zinc-finger domains
possibly result in the loss of DNA binding domains, thus
eliminating their functionality and subsequently interfer-
ing with the expression of various genes under the zinc-
finger gene control. Genes under ZNF407 control have
not been as of yet identified.Figure 3 CLUSTALW sequence alignment between zinc fingers 18 and
highlighted in green), and zinc fingers 2 and 3 of Aart and its linker (
colons, sequence similarity as defined by scores coming from the substitut
residues whose side chains chelate the Zn2+ ion in Aart are underlined (C5
the Serine residue that undergoes the mutation to Tryptophan is in bold. BThe homology modeling approach is justified since the
identity rate between the sequence of an unknown struc-
ture and a sequence whose experimentally available struc-
ture is high. Figure 3 shows the sequence alignment
between fingers 18 and 19 of the target sequence
(ZNF407), as annotated in UniProt, and the sequence cor-
responding to fingers 2 and 3 of the high resolution crystal
structure (Protein Data Bank code 2I13, subunit A) of a
tandem 6-finger zinc finger domain (Aart) bound to a
double-stranded DNA and designed to recognize ANN
triplets [17]. This alignment shows a high degree of iden-
tity between the two sequences (Figure 3). In spite of the
2-residue insertion in the N-terminus of zinc finger 18 of
ZNF407 (Threonine-Tryptophan, Figure 3), the high se-
quence identity (~40%) between the two sequences allows
us to model-build a 3D structure of the ZNF407-DNA
complex in order to visualize the effects of the Serine to
Tryptophan mutation. Since no specific DNA sequence
for ZNF407 binding are available, the interaction of tan-
dem fingers 18 and 19 with the DNA sequence was mod-
eled after the Aart-DNA complex. Figure 4 shows diagrams
of the 3D model of wild type ZNF407 tandem finger do-
mains 18 and 19 wrapped around the major groove of the
double-stranded DNA sequence. The zinc finger linkers are
five residues long in general (residues i to i + 4) and usually
contain a Proline residue at position i + 4. The Proline side
chain is known for its rigidity because of its cyclic character.
Its presence at position i + 4 thus restrains the confor-
mation of the linker, reducing its flexibility, and properly
positioning the α-helix of the C-terminal finger for inter-
action with the target DNA. This is illustrated in the case
of fingers 19 and 20 (Figure 4a). Accordingly, by reducing
the overall conformational entropy, complex formation is
favored energetically and structurally.
The presence of Serine in position i + 4 of the ZNF40718-
19 linker is unusual and carries with it added backbone
flexibility. Nevertheless, this potential flexibility is re-
duced by an H-bond between the hydroxyl group of
S1685 at i + 4 and the carboxyl side chain of E1683 at
i + 2, locking the relative spatial position of the 18 and
19 fingers. This stabilizes the linker in a β-strand-like
conformation and favors the interaction with DNA by
reducing the number of bioactive conformations avail-
able for binding (Figure 4b). A Serine to Tryptophan19 of ZNF407 with their corresponding linker (TGEKS,
TEGKP, highlighted in green). Asterisks denote sequence identity;
ion matrix; and dots, sequences with any small positive scores. The
2, C55, H68, H72 for ZNF407, and C80, C83, H96, and H100 for Aart-A);
asic residues are in blue and acidic in red.
Figure 4 Diagrams of the 3D model of ZNF407 tandem finger domains (rainbow colored) and a double-stranded DNA sequence
(phosphate backbone in orange and bases as green-to-blue sticks). a: Wild type finger 19-finger 20 linker with p.P1713 and p.E1711
(positions i + 4 and i + 2, respectively). b: Wild type fingers 18 and 19 with linker peptide showing p.S1685 H-bonded to p.E1683. One zinc ion
is coordinated by each finger (grey spheres). c: p.S1685W mutant showing the loss of the H-bond to p.E1683.
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H-bond, leading to a more flexible linker, and thus to a
decrease in the probability of zinc finger-DNA complex
formation of downstream partners (Figure 4c). The ex-
pected physiological effects of this physico-chemical
perturbation include interfering with the expression of
genes under ZNF407 control.
DNA- and RNA-binding zinc finger proteins are tran-
scriptional regulators with a major function controlling
developmental cascades of gene expression especially
during fetal brain development. Mutations in such pro-
teins have been found to interfere with normal brain de-
velopment manifested during the developmental period,
thus causing severe mental retardation. They have been
associated with non-syndromic X-linked mental retard-
ation [ZNF81: OMIM 314998 [18]; ZNF674: OMIM
300573 [19], ZNF711: OMIM 300803 [20], autosomal re-
cessive non-syndromic intellectual disability [ZC3H14,
OMIM 613279] [21] and impairment in adaptive behav-
ior that manifest during development.
ZNF407 mRNA, as well as the corresponding protein
are expressed in most normal tissues with moderate nu-
clear and cytoplasmic positivity. These include adult,
embryonic and fetal central and peripheral nervous sys-
tems (http://www.nextprot.org/db/entry/NX_Q9C0G0/ex-
pression). It is not known if there is tissue specificity for
each of the three isoforms or what tissues express the two
isoforms affected by the c.C5054G/p.S1685W mutation.
To date, twenty polymorphisms for ZNF407 have been re-
ported in the Domain Mapping of Disease Mutations
database (DMDM) [22]. The natural variants reported in
the UniProt database entry Q9C0G0 (N69S, G512R,
N972T, S1259L, A1913T) are included in DMDM. None
of these, though, have been associated with known dis-
eases. However, deletion of a critical region on 18q23 that
includes the ZNF407 gene and two other zinc finger genes
(ZNF516 and ZNF236), among other genes, is correlated
with congenital aural atresia (CAA), which manifests a
subset of phenotypes recognized by the 18q deletion
(18q-) syndrome [23]. However, the clinical picturedescribed in this syndrome is probably due to haploin-
sufficiency of several genes, as we could not find any
symptomatic presentation in obligate carriers. Analysis
of several CAA patients led to defining the breakpoint
of the deletion within ZNF407 [24]. Another identified
translocation breakpoint in the third intron of the
ZNF407 gene causes a reduction in the transcript of its
isoform 1, resulting in non-syndromic intellectual im-
pairment and autism [25]. Furthermore, two de novo dam-
aging missense mutations [c.A1436G/p.Y460C; c.C3640G/
p.P1195A] in the very long linker region between zinc fin-
gers 3 and 4, and between 11 and 12, respectively, of the
ZNF407 gene were found in one intellectual impairment
patient each. Both patients were heterozygous, each for
their relevant mutation.
This is the first association of ZNF407 mutation to an
autosomal recessive syndromic intellectual impairment/
mental retardation detected using Whole Exome Se-
quencing of a single affected individual following the de-
termination of specific gene mapping intervals through
homozygosity mapping. This proved to be the most effi-
cient approach to gene and mutation identification, as
compared to multiple family-member Whole Exome Se-
quencing with the resulting comparative analyses, or to
candidate gene screening by Sanger sequencing when
multiple candidates exist.
Next Generation Exome and Genome sequencing have
clearly demonstrated that humans harbor numerous dele-
terious mutations with no apparent ill effect [26,27]. The
built-in redundancy in the human genome provides alter-
nate pathways that make possible compensation for dele-
terious mutations in important genes without which there
would be incompatibility with life. Thus, deleterious mu-
tations resulting from NGS data need to be supported by
additional genomic or functional data whenever possible.
The ZNF407 c.C5054G/p.S1685W mutation is the only
mutation that lies within one of the homozygosity inter-
vals that is certain to harbor the offending gene that could
not be excluded as the disease causing mutation. It co-
segregates with the disease phenotype within the family, it
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able databases or in the ethnic population and it affects an
evolutionarily highly conserved amino acid. Normal se-
quence variants [polymorphisms] have not been reported
in ZNF407 linker regions (between zinc fingers) providing
further evidence of the sequence specificity required by
these regions for normal function and subsequently for
the damaging effects of the mutation. Extensive protein
modeling clearly indicates that the mutation interferes
with the normal function of the ZNF407 protein.
Taken together, these data highlight the significance of
the c.C5054G/p.S1685W mutation and the role of the
ZNF407 gene in controlling the expression of down-
stream genes involved in pathways leading to normal
fetal brain development. Once disrupted, one or more
dimensions of brain development get affected. With this
pausing as a pivotal step in normal brain development, it
is worth understanding the underlying molecular mech-
anism by which this mutation eliminates or significantly
alters the functionality of ZNF407, thus compromising
the developmental pathway ZNF407 is involved in. The
model presented proposes a rational account of such
molecular mechanism.Competing interests
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